ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,291, issued on Aug. 5, was assigned to Revolo Biotherapeutics Ltd. (Great Shelford, Great Britain).
"Method for the treatment of allergic rhinitis" was invented by Andrew Lightfoot (Cambridgeshire, Great Britain), Nicola Cooper (Cambridgeshire, Great Britain) and Donata Federici Canova (Cambridgeshire, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a re...